Navigating the Complex CMC Landscape of ATMPs and CGTs The development of Advanced Therapy Medicinal Products (ATMPs), and Cell and Gene Therapies (CGTs) opens up exciting possibilities for treating previously untreatable conditions. The complexity of these therapies is very challenging and requires meticulous attention to the pharmaceutical development to ensure their quality,The post Navigating the Complex CMC Landscape of ATMPs and CGTs appeared first on Celegence.
Celegence is an Illinois-based firm that provides services such as medical writing, regulatory operations management and compliance consulting for the life sciences industry.